Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
272.66
+0.94 (0.35%)
Nov 9, 2026, 2:48 PM EST - Market open
Cardinal Health Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 257,752 | 254,248 | 222,578 | 226,827 | 204,979 | 181,326 | |
Revenue Growth | 10.01% | 14.23% | -1.87% | 10.66% | 13.04% | 11.61% |
Cost of Revenue | 247,701 | 244,474 | 214,410 | 219,413 | 198,105 | 174,842 |
Gross Profit | 10,051 | 9,774 | 8,168 | 7,414 | 6,874 | 6,484 |
Selling, General & Admin | 6,259 | 6,125 | 5,379 | 5,000 | 4,800 | 4,512 |
Amortization of Goodwill & Intangibles | 374 | 361 | 303 | 284 | 285 | 324 |
Operating Expenses | 6,633 | 6,486 | 5,682 | 5,284 | 5,085 | 4,836 |
Operating Income | 3,418 | 3,288 | 2,486 | 2,130 | 1,789 | 1,648 |
Interest Expense | -341 | -348 | -215 | -51 | -84 | -147 |
Currency Exchange Gain (Loss) | -4 | -4 | -6 | 1 | -7 | - |
Other Non Operating Income (Expenses) | 31 | 35 | 47 | 8 | 2 | -22 |
EBT Excluding Unusual Items | 3,104 | 2,971 | 2,312 | 2,088 | 1,700 | 1,479 |
Merger & Restructuring Charges | -606 | -508 | -378 | -175 | -95 | -101 |
Impairment of Goodwill | -184 | -184 | - | -675 | -1,200 | -2,100 |
Gain (Loss) on Sale of Investments | -120 | -122 | - | - | - | 2 |
Asset Writedown | 13 | 7 | -18 | 41 | -46 | 40 |
Legal Settlements | 57 | 10 | 185 | -78 | 304 | -94 |
Other Unusual Items | - | - | - | - | - | -10 |
Pretax Income | 2,264 | 2,174 | 2,101 | 1,201 | 663 | -784 |
Income Tax Expense | 457 | 469 | 532 | 348 | 332 | 153 |
Earnings From Continuing Operations | 1,807 | 1,705 | 1,569 | 853 | 331 | -937 |
Minority Interest in Earnings | 11 | 9 | -8 | -1 | -1 | -1 |
Net Income | 1,818 | 1,714 | 1,561 | 852 | 330 | -938 |
Net Income to Common | 1,818 | 1,714 | 1,561 | 852 | 330 | -938 |
Net Income Growth | 13.98% | 9.80% | 83.22% | 158.18% | - | - |
Shares Outstanding (Basic) | 235 | 236 | 241 | 245 | 261 | 279 |
Shares Outstanding (Diluted) | 236 | 237 | 242 | 247 | 262 | 279 |
Shares Change | -2.08% | -2.07% | -2.02% | -5.73% | -6.09% | -5.10% |
EPS (Basic) | 7.75 | 7.26 | 6.48 | 3.48 | 1.26 | -3.36 |
EPS (Diluted) | 7.72 | 7.23 | 6.45 | 3.45 | 1.26 | -3.37 |
EPS Growth | 16.54% | 12.09% | 86.96% | 173.81% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 4,901 | 4,525 | 1,850 | 3,251 | 2,363 | 2,788 |
Free Cash Flow Per Share | 20.81 | 19.09 | 7.64 | 13.16 | 9.02 | 9.99 |
Dividend Per Share | 2.053 | 2.048 | 2.027 | 2.007 | 1.988 | 1.968 |
Dividend Growth | 1.00% | 1.01% | 1.00% | 0.99% | 1.00% | 1.45% |
Gross Margin | 3.90% | 3.84% | 3.67% | 3.27% | 3.35% | 3.58% |
Operating Margin | 1.33% | 1.29% | 1.12% | 0.94% | 0.87% | 0.91% |
Profit Margin | 0.70% | 0.67% | 0.70% | 0.38% | 0.16% | -0.52% |
Free Cash Flow Margin | 1.90% | 1.78% | 0.83% | 1.43% | 1.15% | 1.54% |
EBITDA | 4,388 | 4,244 | 3,276 | 2,840 | 2,481 | 2,340 |
EBITDA Margin | 1.70% | 1.67% | 1.47% | 1.25% | 1.21% | 1.29% |
D&A For EBITDA | 970 | 956 | 790 | 710 | 692 | 692 |
EBIT | 3,418 | 3,288 | 2,486 | 2,130 | 1,789 | 1,648 |
EBIT Margin | 1.33% | 1.29% | 1.12% | 0.94% | 0.87% | 0.91% |
Effective Tax Rate | 20.19% | 21.57% | 25.32% | 28.98% | 50.08% | - |